{"id":"https://openalex.org/W2083666482","doi":"https://doi.org/10.1016/j.jconrel.2009.03.014","title":"Development of a sustained-release recombinant human growth hormone formulation","display_name":"Development of a sustained-release recombinant human growth hormone formulation","publication_year":2009,"publication_date":"2009-03-30","ids":{"openalex":"https://openalex.org/W2083666482","doi":"https://doi.org/10.1016/j.jconrel.2009.03.014","mag":"2083666482","pmid":"https://pubmed.ncbi.nlm.nih.gov/19332090"},"language":"en","primary_location":{"id":"doi:10.1016/j.jconrel.2009.03.014","doi":"https://doi.org/10.1016/j.jconrel.2009.03.014","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jconrel.2009.03.014","pdf_url":null,"source":{"id":"https://openalex.org/S161954266","display_name":"Journal of Controlled Release","issn_l":"0168-3659","issn":["0168-3659","1873-4995"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Controlled Release","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5114139415","display_name":"Heechun Kwak","orcid":"https://orcid.org/0009-0005-3598-8877","observed_orcids":["https://orcid.org/0009-0005-3598-8877"]},"institutions":[{"id":"https://openalex.org/I139264467","display_name":"Seoul National University","ror":"https://ror.org/04h9pn542","country_code":"KR","type":"education","lineage":["https://openalex.org/I139264467"]},{"id":"https://openalex.org/I4210155763","display_name":"Dong-A Pharmaceutical (South Korea)","ror":"https://ror.org/05ctcx759","country_code":"KR","type":"company","lineage":["https://openalex.org/I4210155763"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"H.H. Kwak","raw_affiliation_strings":["Biopharmaceutical Research Laboratory, Dong-A Pharm. Co. Ltd., Gyeonggi, 446-905, Republic of Korea","National Research Laboratory for Transporters Targeted Drug Design, College of Pharmacy, Seoul National University, Seoul 151-742, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biopharmaceutical Research Laboratory, Dong-A Pharm. Co. Ltd., Gyeonggi, 446-905, Republic of Korea","institution_ids":["https://openalex.org/I4210155763"]},{"raw_affiliation_string":"National Research Laboratory for Transporters Targeted Drug Design, College of Pharmacy, Seoul National University, Seoul 151-742, Republic of Korea","institution_ids":["https://openalex.org/I139264467"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039386992","display_name":"Won\u2010Sik Shim","orcid":"https://orcid.org/0000-0002-1020-685X","observed_orcids":["https://orcid.org/0000-0002-1020-685X"]},"institutions":[{"id":"https://openalex.org/I139264467","display_name":"Seoul National University","ror":"https://ror.org/04h9pn542","country_code":"KR","type":"education","lineage":["https://openalex.org/I139264467"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"W.S. Shim","raw_affiliation_strings":["National Research Laboratory for Transporters Targeted Drug Design, College of Pharmacy, Seoul National University, Seoul 151-742, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Research Laboratory for Transporters Targeted Drug Design, College of Pharmacy, Seoul National University, Seoul 151-742, Republic of Korea","institution_ids":["https://openalex.org/I139264467"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028334345","display_name":"Min\u2010Koo Choi","orcid":"https://orcid.org/0000-0003-0217-5042","observed_orcids":["https://orcid.org/0000-0003-0217-5042"]},"institutions":[{"id":"https://openalex.org/I139264467","display_name":"Seoul National University","ror":"https://ror.org/04h9pn542","country_code":"KR","type":"education","lineage":["https://openalex.org/I139264467"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"M.K. Choi","raw_affiliation_strings":["National Research Laboratory for Transporters Targeted Drug Design, College of Pharmacy, Seoul National University, Seoul 151-742, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Research Laboratory for Transporters Targeted Drug Design, College of Pharmacy, Seoul National University, Seoul 151-742, Republic of Korea","institution_ids":["https://openalex.org/I139264467"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110163501","display_name":"Mi-Kyung Son","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155763","display_name":"Dong-A Pharmaceutical (South Korea)","ror":"https://ror.org/05ctcx759","country_code":"KR","type":"company","lineage":["https://openalex.org/I4210155763"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"M.K. Son","raw_affiliation_strings":["Biopharmaceutical Research Laboratory, Dong-A Pharm. Co. Ltd., Gyeonggi, 446-905, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biopharmaceutical Research Laboratory, Dong-A Pharm. Co. Ltd., Gyeonggi, 446-905, Republic of Korea","institution_ids":["https://openalex.org/I4210155763"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011069333","display_name":"Y.J. Kim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155763","display_name":"Dong-A Pharmaceutical (South Korea)","ror":"https://ror.org/05ctcx759","country_code":"KR","type":"company","lineage":["https://openalex.org/I4210155763"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Y.J. Kim","raw_affiliation_strings":["Biopharmaceutical Research Laboratory, Dong-A Pharm. Co. Ltd., Gyeonggi, 446-905, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biopharmaceutical Research Laboratory, Dong-A Pharm. Co. Ltd., Gyeonggi, 446-905, Republic of Korea","institution_ids":["https://openalex.org/I4210155763"]}]},{"author_position":"middle","author":{"id":null,"display_name":"H.C. Yang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155763","display_name":"Dong-A Pharmaceutical (South Korea)","ror":"https://ror.org/05ctcx759","country_code":"KR","type":"company","lineage":["https://openalex.org/I4210155763"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"H.C. Yang","raw_affiliation_strings":["Biopharmaceutical Research Laboratory, Dong-A Pharm. Co. Ltd., Gyeonggi, 446-905, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biopharmaceutical Research Laboratory, Dong-A Pharm. Co. Ltd., Gyeonggi, 446-905, Republic of Korea","institution_ids":["https://openalex.org/I4210155763"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077558219","display_name":"T.H. Kim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155763","display_name":"Dong-A Pharmaceutical (South Korea)","ror":"https://ror.org/05ctcx759","country_code":"KR","type":"company","lineage":["https://openalex.org/I4210155763"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"T.H. Kim","raw_affiliation_strings":["Biopharmaceutical Research Laboratory, Dong-A Pharm. Co. Ltd., Gyeonggi, 446-905, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biopharmaceutical Research Laboratory, Dong-A Pharm. Co. Ltd., Gyeonggi, 446-905, Republic of Korea","institution_ids":["https://openalex.org/I4210155763"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039693536","display_name":"G.I. Lee","orcid":"https://orcid.org/0009-0004-9005-0139","observed_orcids":["https://orcid.org/0009-0004-9005-0139"]},"institutions":[{"id":"https://openalex.org/I4210155763","display_name":"Dong-A Pharmaceutical (South Korea)","ror":"https://ror.org/05ctcx759","country_code":"KR","type":"company","lineage":["https://openalex.org/I4210155763"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"G.I. Lee","raw_affiliation_strings":["Biopharmaceutical Research Laboratory, Dong-A Pharm. Co. Ltd., Gyeonggi, 446-905, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biopharmaceutical Research Laboratory, Dong-A Pharm. Co. Ltd., Gyeonggi, 446-905, Republic of Korea","institution_ids":["https://openalex.org/I4210155763"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003691717","display_name":"B.M. Kim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155763","display_name":"Dong-A Pharmaceutical (South Korea)","ror":"https://ror.org/05ctcx759","country_code":"KR","type":"company","lineage":["https://openalex.org/I4210155763"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"B.M. Kim","raw_affiliation_strings":["Biopharmaceutical Research Laboratory, Dong-A Pharm. Co. Ltd., Gyeonggi, 446-905, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biopharmaceutical Research Laboratory, Dong-A Pharm. Co. Ltd., Gyeonggi, 446-905, Republic of Korea","institution_ids":["https://openalex.org/I4210155763"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048776540","display_name":"Seung-Woo Kang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155763","display_name":"Dong-A Pharmaceutical (South Korea)","ror":"https://ror.org/05ctcx759","country_code":"KR","type":"company","lineage":["https://openalex.org/I4210155763"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"S.H. Kang","raw_affiliation_strings":["Biopharmaceutical Research Laboratory, Dong-A Pharm. Co. Ltd., Gyeonggi, 446-905, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biopharmaceutical Research Laboratory, Dong-A Pharm. Co. Ltd., Gyeonggi, 446-905, Republic of Korea","institution_ids":["https://openalex.org/I4210155763"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091547688","display_name":"Chang\u2010Koo Shim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I139264467","display_name":"Seoul National University","ror":"https://ror.org/04h9pn542","country_code":"KR","type":"education","lineage":["https://openalex.org/I139264467"]}],"countries":["KR"],"is_corresponding":true,"raw_author_name":"C.K. Shim","raw_affiliation_strings":["National Research Laboratory for Transporters Targeted Drug Design, College of Pharmacy, Seoul National University, Seoul 151-742, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Research Laboratory for Transporters Targeted Drug Design, College of Pharmacy, Seoul National University, Seoul 151-742, Republic of Korea","institution_ids":["https://openalex.org/I139264467"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5091547688"],"corresponding_institution_ids":["https://openalex.org/I139264467"],"apc_list":{"value":4440,"currency":"USD","value_usd":4440},"apc_paid":null,"fwci":2.175,"has_fulltext":false,"cited_by_count":60,"citation_normalized_percentile":{"value":0.87612067,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"137","issue":"2","first_page":"160","last_page":"165"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10748","display_name":"Growth Hormone and Insulin-like Growth Factors","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10748","display_name":"Growth Hormone and Insulin-like Growth Factors","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.011500000022351742,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/recombinant-human-growth-hormone","display_name":"recombinant human growth hormone","score":0.9980000257492065},{"id":"https://openalex.org/keywords/extended-release-formulation","display_name":"sustained-release formulation","score":0.9829999804496765},{"id":"https://openalex.org/keywords/short-stature","display_name":"short stature","score":0.8080000281333923},{"id":"https://openalex.org/keywords/plga","display_name":"PLGA","score":0.5490000247955322},{"id":"https://openalex.org/keywords/double-emulsion-solvent-evaporation","display_name":"double emulsion solvent evaporation","score":0.953000009059906},{"id":"https://openalex.org/keywords/hydroxypropyl-beta-cyclodextrin","display_name":"hydroxypropyl-\u03b2-cyclodextrin","score":0.9269999861717224},{"id":"https://openalex.org/keywords/zinc-oxide","display_name":"zinc oxide","score":0.8379999995231628},{"id":"https://openalex.org/keywords/insulin-like-growth-factor-i","display_name":"insulin-like growth factor I","score":0.8889999985694885},{"id":"https://openalex.org/keywords/igfbp-3","display_name":"IGFBP-3","score":0.8389999866485596},{"id":"https://openalex.org/keywords/antibody-production","display_name":"antibody production","score":0.5960000157356262},{"id":"https://openalex.org/keywords/once-weekly-dosing","display_name":"weekly dosing","score":0.9100000262260437},{"id":"https://openalex.org/keywords/growth-plate","display_name":"growth plate","score":0.5540000200271606},{"id":"https://openalex.org/keywords/hypophysectomized-rats","display_name":"hypophysectomized rats","score":0.8169999718666077},{"id":"https://openalex.org/keywords/monkeys","display_name":"monkeys","score":0.38499999046325684}],"concepts":[{"id":"https://openalex.org/C2994100043","wikidata":"https://www.wikidata.org/wiki/Q29956617","display_name":"Human growth hormone","level":4,"score":0.8245647549629211},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.6772933006286621},{"id":"https://openalex.org/C2984496839","wikidata":"https://www.wikidata.org/wiki/Q29956617","display_name":"Growth hormone","level":3,"score":0.47726577520370483},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4306173026561737},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3205539584159851},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.2789660096168518},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.23846545815467834},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2116754651069641},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000073738","descriptor_name":"2-Hydroxypropyl-beta-cyclodextrin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000917","descriptor_name":"Antibody Formation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008253","descriptor_name":"Macaca mulatta","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008855","descriptor_name":"Microscopy, Electron, Scanning","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008863","descriptor_name":"Microspheres","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011098","descriptor_name":"Polyglactin 910","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015034","descriptor_name":"Zinc Oxide","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D015430","descriptor_name":"Weight Gain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019382","descriptor_name":"Human Growth Hormone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D019382","descriptor_name":"Human Growth Hormone","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D019382","descriptor_name":"Human Growth Hormone","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D019382","descriptor_name":"Human Growth Hormone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D047392","descriptor_name":"beta-Cyclodextrins","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.jconrel.2009.03.014","doi":"https://doi.org/10.1016/j.jconrel.2009.03.014","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jconrel.2009.03.014","pdf_url":null,"source":{"id":"https://openalex.org/S161954266","display_name":"Journal of Controlled Release","issn_l":"0168-3659","issn":["0168-3659","1873-4995"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Controlled Release","raw_type":"journal-article"},{"id":"pmid:19332090","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19332090","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of controlled release : official journal of the Controlled Release Society","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W101810696","https://openalex.org/W190467796","https://openalex.org/W1589692368","https://openalex.org/W1855555312","https://openalex.org/W1964807748","https://openalex.org/W1965163412","https://openalex.org/W1971700667","https://openalex.org/W1973158756","https://openalex.org/W1984223992","https://openalex.org/W1989641932","https://openalex.org/W1999422042","https://openalex.org/W2012292312","https://openalex.org/W2019380237","https://openalex.org/W2026870334","https://openalex.org/W2047534346","https://openalex.org/W2056601190","https://openalex.org/W2080798052","https://openalex.org/W2088649681","https://openalex.org/W2090123343","https://openalex.org/W2091995525","https://openalex.org/W2119791875","https://openalex.org/W2120835767","https://openalex.org/W2136096736","https://openalex.org/W2138080929","https://openalex.org/W2167362914","https://openalex.org/W2342585027","https://openalex.org/W4247966618","https://openalex.org/W6604150153","https://openalex.org/W6673550905"],"related_works":["https://openalex.org/W1999422042","https://openalex.org/W1557469254","https://openalex.org/W2075234837","https://openalex.org/W2136096736","https://openalex.org/W2010384527","https://openalex.org/W2044831211","https://openalex.org/W1987480200","https://openalex.org/W2087349742","https://openalex.org/W2182427056","https://openalex.org/W1989641932"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":4},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}